Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii
about
sameAs
A mechanism for the synergistic antimalarial action of atovaquone and proguanilEndochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosisDrug repurposing and human parasitic protozoan diseasesStructural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug actionIn vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondiiAnti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacinQuinupristin-dalfopristin is active against Toxoplasma gondiiSynergistic effect of clindamycin and atovaquone in acute murine toxoplasmosisActivity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondiiAtovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisTwo 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondiiRifabutin is active in murine models of toxoplasmosisNonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondiiActivity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosisRifapentine is active in vitro and in vivo against Toxoplasma gondiiThe ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionTrovafloxacin is active against Toxoplasma gondiiIn vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondiiTreatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosisGreat efficacy of sulfachloropyrazine-sodium against acute murine toxoplasmosisBCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium bergheiParameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex.Host cell egress and invasion induce marked relocations of glycolytic enzymes in Toxoplasma gondii tachyzoites.In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii.Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group.Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat modelActivity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.Cryptogenic epilepsy: an infectious etiology?Antiparasitic agent atovaquoneFeline ocular toxoplasmosis.Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compoundsMolecular basis for atovaquone binding to the cytochrome bc1 complex.JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium.Toxoplasmosis, an overview with emphasis on ocular involvement.Toxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs in vitro.An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondiiEffect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in miceActivity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures.Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo
P2860
Q24550657-27D1EE9F-5B0E-4795-9431-3C5FEA77D1E7Q24630917-5D31358C-9228-4E16-B4BB-3EB493521EBDQ26999453-B11B4302-6645-4848-BF0D-1DA62278DD81Q27690642-F1D8E38E-0B31-4393-A0E2-C79FC32D9A49Q28320236-66797BDD-400F-418D-9A3A-545126AC53FCQ28343422-A88F505A-EB32-4B88-80E8-B40CA6E687C8Q28343473-2FBEF90B-C74A-448D-A23F-028EEB05A489Q28343549-B7034BA6-5E79-4A43-AB7A-778887F91EEDQ28345231-D7D96D24-3227-4267-8EE4-7CB1CC0AD2AAQ28365205-92CEEEF4-0D8A-4CD0-B262-6C1CB07EA223Q28368883-E9A89EB6-8CF8-47D3-882E-48E04DB48E7FQ28369142-E4FDE244-1F24-44D6-9265-41F2F83E2EF6Q28378281-1DC36DF2-2C62-4EE0-8232-F7F4B5065B35Q28378795-5CCDC7D4-EA10-4EC3-B2B3-D81B7B01E952Q28378877-3A20572E-6567-4603-B818-36D0893FBD2DQ28378988-27A97502-B7BA-4F2E-8884-5638B6BDE9ECQ28379168-AA3B118F-C348-4331-AA31-ACB84A9A7501Q28379193-09E05A8A-B3BB-4B46-92EF-B0473F145B2AQ28379243-7CB80B5E-D10A-4186-8470-88276DF3356AQ28379387-B709138B-4067-40E2-859F-E3FF70312DACQ28396159-E31C31AC-69D2-493C-B081-7E3DA2C7D9DBQ28540877-CEFF1430-9D56-4B1B-B179-5C61928CCE26Q33279892-70BC1C6B-7863-4EAA-9018-BD279C377F31Q33379077-B818D5D8-4421-4949-BE33-B568A5C8DA95Q33558897-9B5EC5CE-F0B2-441B-8CC6-690A0CFFB62DQ33693150-CF56A962-F1F0-4446-ACE2-F073B334FEE3Q33695186-4D424468-DE89-471A-ABCB-9D9FB4B66167Q33745394-29546C08-83C8-490A-A98D-5701339B9394Q34083253-A69B0B6B-8A2D-45CE-B563-05772FF9FFBDQ34107885-66261F59-024F-471E-93AB-1A50B51D89DEQ34276691-F846D6DE-64D1-477D-9FCD-D4A2302D7B7EQ34290022-9BF3DABE-550E-4F2B-8514-81EAD6EB012BQ34534276-D7C7EFF9-8FAE-43C6-A3CD-37EEEE24C006Q34922167-6026E1DF-8BF0-4B0E-ADFE-404CC369B123Q35014158-DFCA47BE-3608-4CDD-8811-AD62EF552157Q35899924-07E197D5-BF60-40BF-B2B9-82C441013862Q36028890-176F2685-48EE-4146-A9BA-675CAC45EEDCQ36753517-67B77D71-99A0-4C70-9E1E-0009A713A215Q36754982-2E88823F-5458-4D96-A601-665CCCDCF005Q36804253-F477A675-4918-4D42-BA12-B4A01406918F
P2860
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii
description
1991 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1991
@ast
im Februar 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: February 1991)
@en
vedecký článok (publikovaný 1991-02)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd in 1991-02)
@nl
наукова стаття, опублікована в лютому 1991
@uk
مقالة علمية (نشرت في فبراير 1991)
@ar
name
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@ast
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@en
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@nl
type
label
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@ast
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@en
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@nl
prefLabel
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@ast
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@en
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@nl
P2093
P2860
P356
P1476
Remarkable in vitro and in viv ...... sue cysts of Toxoplasma gondii
@en
P2093
F G Araujo
J Huskinson
J S Remington
P2860
P356
10.1128/AAC.35.2.293
P407
P577
1991-02-01T00:00:00Z